ICU Medical, Inc. (NASDAQ:ICUI) Position Increased by Citigroup Inc.

Citigroup Inc. raised its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 100.4% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 28,965 shares of the medical instruments supplier’s stock after buying an additional 14,512 shares during the period. Citigroup Inc.’s holdings in ICU Medical were worth $5,278,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of ICUI. Victory Capital Management Inc. raised its holdings in shares of ICU Medical by 2,966.3% during the second quarter. Victory Capital Management Inc. now owns 141,848 shares of the medical instruments supplier’s stock valued at $16,844,000 after acquiring an additional 137,222 shares during the period. Millennium Management LLC grew its position in ICU Medical by 327.8% during the 2nd quarter. Millennium Management LLC now owns 136,070 shares of the medical instruments supplier’s stock worth $16,158,000 after purchasing an additional 104,264 shares in the last quarter. Granite Investment Partners LLC purchased a new stake in shares of ICU Medical in the second quarter valued at $10,650,000. F M Investments LLC acquired a new stake in shares of ICU Medical in the second quarter worth $10,175,000. Finally, Dimensional Fund Advisors LP boosted its position in ICU Medical by 21.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 311,542 shares of the medical instruments supplier’s stock worth $36,996,000 after acquiring an additional 55,588 shares during the period. Institutional investors and hedge funds own 96.10% of the company’s stock.

Insider Activity at ICU Medical

In other news, CEO Vivek Jain sold 12,000 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $162.91, for a total value of $1,954,920.00. Following the sale, the chief executive officer now owns 104,593 shares of the company’s stock, valued at approximately $17,039,245.63. This represents a 10.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Christian B. Voigtlander sold 1,430 shares of the business’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total transaction of $225,940.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 40,364 shares of company stock worth $6,869,878. 6.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. KeyCorp increased their price objective on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a report on Wednesday, November 13th. Jefferies Financial Group initiated coverage on ICU Medical in a research report on Monday, October 14th. They issued a “hold” rating and a $183.00 price target for the company. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Raymond James boosted their target price on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $173.00.

ICU Medical Stock Down 1.8 %

Shares of ICUI opened at $160.96 on Tuesday. The company has a 50-day simple moving average of $174.60 and a 200-day simple moving average of $147.67. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. ICU Medical, Inc. has a 52 week low of $83.26 and a 52 week high of $196.26. The firm has a market capitalization of $3.94 billion, a P/E ratio of -36.42 and a beta of 0.66.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.